Cantab IP provides valuable input at every part of the invention patenting process to reduce the risks of failure and to minimise costs.

Cantab IP specialises in patent drafting, including the drafting of biotech patent, pharmaceutical patent and life sciences patent specifications.

We help in the early stages by reviewing invention disclosures, assisting in invention spotting and advising on the possible types of protection and claims available. This way, an informed decision can be made by the inventor or applicant as to whether to proceed with a patent draft.

We can advise on the various routes available to protect inventions internationally and can help structure an efficient patent filing programme.

We have experience in drafting patent applications in the following fields (among others): medical equipment, medical technology (medtech), diagnostic kits, drug screening, oncology and cancer biology (breast cancer, liver cancer, etc), tumour therapy, drug delivery, microarray technologies, genes (e.g., cell cycle genes), proteins (e.g., zinc fingers, GPCRs), nucleic acid sequences, polypeptide sequences, cell lines, cell culture, embryonic stem cells, developmental biology, antibody technology, tropical diseases (e.g., dengue, chikungunya), allergy, pharmaceuticals, combination therapies, etc

We also handle post-grant matters, including post-grant patent examination, patent opposition, patent amendment and patent revocation.

Cantab IP helps clients understand the patent landscape and analyse third party patents which might affect their commercial activities (freedom to operate, FTO).

For more information, please see our Strategic and Advisory Services page.

Cantab LLP • V Box 881846 • Singapore 919191

mail [at] cantab-ip [dot] com